Results 161 to 170 of about 87,340 (291)
Complex Factors in Hydrocephalus Development in Tuberous Sclerosis Complex: A Case Report of Subependymal Giant Cell Astrocytoma [PDF]
Hajime Nakamura +4 more
openalex +1 more source
In U87 cells, meranzin hydrate showed cytotoxicity (MIC = 50 μM) and anti‐invasion activity (IC50 = 33.12 μM) but had no inhibitory effect on colony formation. It also suppressed the cancer stem cell property of sphere formation (IC50 = 21.43 μM). In silico analysis indicated that meranzin hydrate may downregulate the protein expression of ALDH1A1 and ...
Shi‐Ying Huang +10 more
wiley +1 more source
An Integrated Engineering Approach to Creating Health‐Modulating Postbiotics
Postbiotics have emerged as a promising alternative to live probiotics, offering comparable health benefits while overcoming challenges related to safety, stability, and shelf life. The review addresses current challenges in standardizing postbiotic definitions and production processes, and by outlining future research directions necessary to unlock ...
Michael Leonidas Chikindas +10 more
wiley +1 more source
Abstract Purpose Metabolite concentrations are valuable biomarkers in brain tumors (BTs). However, absolute quantification of metabolites using MR spectroscopy requires a correction of water relaxation using time‐consuming quantitative MRI (qMRI) sequences in addition to a lengthy two‐dimensional spectroscopic water‐reference acquisition.
Dennis C. Thomas +5 more
wiley +1 more source
A Challenging Case of Corpus Callosum Anaplastic Astrocytoma
Ahmed K A Ahmed +4 more
openalex +1 more source
Magnetic Resonance Spectroscopy of Cystathionine and 2‐Hydroxyglutarate in Brain Tumors
Cystathionine and 2‐hydroxyglutarate were evaluated in 38 glioma patients with TE 97ms PRESS at 3T. Cystathionine level was significantly higher in IDH‐mutant 1p/19q‐codeleted gliomas than in IDH‐mutant non‐codeleted gliomas (p = 0.002). The sensitivity and specificity of the cystathionine measures with respect to 1p/19q status were 0.8 and 0.79, while
Changho Choi +17 more
wiley +1 more source
ABSTRACT Background Minoritized childhood cancer survivors (CCS) may encounter barriers to timely late effects surveillance. We aimed to evaluate clinical and demographic differences in the likelihood of, and timing to, growth hormone deficiency (GHD) screening, evaluation, diagnosis, and treatment among at‐risk CCS treated with radiation therapy (RT).
Fulfilled Ighalo +7 more
wiley +1 more source

